47 hasil untuk "Detappe, Alexandre"
Menampilkan 1–20 · 0,65 detik · RSS
-
Artikel Jurnal Teks lengkap
The effect of flattening filter free delivery on endothelial dose enhancement with gold nanoparticles
Purpose: The aim of this study is to quantify and to compare the dose enhancement factor from gold nanoparticles (AuNP) to tumor endothelial cells for different concentrations of AuNP, and clinical MV beam configurations. Methods: Tumor endothelial cells are modeled as slabs measuring 10 × 10 × 2…
-
Artikel Jurnal Teks lengkap
Low Z target switching to increase tumor endothelial cell dose enhancement during gold nanoparticle-aided radiation therapy
PURPOSE: Previous studies have introduced gold nanoparticles as vascular-disrupting agents during radiation therapy. Crucial to this concept is the low energy photon content of the therapy radiation beam. The authors introduce a new mode of delivery including a linear accelerator target that can…
-
Artikel Jurnal Teks lengkap
AGuIX nanoparticles as a promising platform for image-guided radiation therapy
AGuIX are gadolinium-based nanoparticles developed mainly for imaging due to their MR contrast properties. They also have a potential role in radiation therapy as a radiosensitizer. We used MRI to quantify the uptake of AGuIX in pancreatic cancer cells, and TEM for intracellular localization. We…
-
Artikel Jurnal Teks lengkap
Stereotactic modulation of blood-brain barrier permeability to enhance drug delivery
Drug delivery in the CNS is limited by endothelial tight junctions forming the impermeable blood-brain barrier. The development of new treatment paradigms has previously been hampered by the restrictiveness of the blood-brain barrier to systemically administered therapeutics. With recent advances…
-
Artikel Jurnal Teks lengkap
Fluorescence monitoring of rare circulating tumor cell and cluster dissemination in a multiple myeloma xenograft model in vivo
Circulating tumor cells (CTCs) are of great interest in cancer research because of their crucial role in hematogenous metastasis. We recently developed “diffuse in vivo flow cytometry” (DiFC), a preclinical research tool for enumerating extremely rare fluorescently labeled CTCs directly in vivo. In…
-
Artikel Jurnal Teks lengkap
Anti‐BCMA Immuno‐NanoPET Radiotracers for Improved Detection of Multiple Myeloma
Current clinical imaging modalities for the sensitive and specific detection of multiple myeloma (MM) rely on nonspecific imaging contrast agents based on gadolinium chelates for magnetic resonance imaging (MRI) or for (18)F‐FDG‐directed and combined positron emission tomography (PET) and computed…
-
Artikel Jurnal Teks lengkap
Ultrasmall Silica-Based Bismuth Gadolinium Nanoparticles for Dual Magnetic Resonance–Computed Tomography Image Guided Radiation Therapy
Selective killing of cancer cells while minimizing damage to healthy tissues is the goal of clinical radiation therapy. This therapeutic ratio can be improved by image-guided radiation delivery and selective radiosensitization of cancer cells. Here, we have designed and tested a novel trimodal…
-
Artikel Jurnal Teks lengkap
New potential for enhancing concomitant chemoradiotherapy with FDA approved concentrations of cisplatin via the photoelectric effect
We predict, for the first time, that by using United States Food and Drug Administration approved concentrations of cisplatin, major radiosensitization may be achieved via photoelectric mechanism during concomitant chemoradiotherapy (CCRT). Our analytical calculations estimate that radiotherapy…
-
Artikel Jurnal Teks lengkap
Influence of pneumatic transportation on the stability of monoclonal antibodies
Pneumatic transportation systems (PTS) were recently proposed as a method to carry ready-for-injection diluted monoclonal antibodies (mAbs) from the pharmacy to the bedside of patients. This method reduces transportation time and improves the efficiency of drug distribution process. However, mAbs…
-
Artikel Jurnal Teks lengkap
Key clinical beam parameters for nanoparticle-mediated radiation dose amplification
As nanoparticle solutions move towards human clinical trials in radiation therapy, the influence of key clinical beam parameters on therapeutic efficacy must be considered. In this study, we have investigated the clinical radiation therapy delivery variables that may significantly affect…
-
Artikel Jurnal Teks lengkap
Differences in Nanoparticle Uptake in Transplanted and Autochthonous Models of Pancreatic Cancer
Human pancreatic ductal adenocarcinoma (PDAC) contains a distinctively dense stroma that limits the accessibility of anticancer drugs, contributing to its poor overall prognosis. Nanoparticles can enhance drug delivery and retention in pancreatic tumors and have been utilized clinically for their…
-
Artikel Jurnal Teks lengkap
Multifaceted Impact of MicroRNA 493-5p on Genome-Stabilizing Pathways Induces Platinum and PARP Inhibitor Resistance in BRCA2-Mutated Carcinomas
BRCA1/2-mutated ovarian cancers (OCs) are defective in homologous recombination repair (HRR) of double-strand breaks (DSBs) and thereby sensitive to platinum and PARP inhibitors (PARPis). Multiple PARPis have recently received US Food and Drug Administration (FDA) approval for treatment of OCs, and…
-
Artikel Jurnal Teks lengkap
Nanoparticle Mediated Tumor Vascular Disruption: A Novel Strategy in Radiation Therapy
More than 50% of all cancer patients receive radiation therapy. The clinical delivery of curative radiation dose is strictly restricted by the proximal healthy tissues. We propose a dual-targeting strategy using vessel-targeted-radio-sensitizing gold nanoparticles and conformal-image guided…
-
Artikel Jurnal Teks lengkap
Retraction of: “Nanoparticle Mediated Tumor Vascular Disruption: A Novel Strategy in Radiation Therapy”
-
Artikel Jurnal Teks lengkap
Anti-MUC1-C Antibody—Conjugated Nanoparticles Potentiate the Efficacy of Fractionated Radiation Therapy
PURPOSE: Heavy-metal chelators and inorganic nanoparticles (NPs) have been examined as potential radioenhancers to increase the efficacy of external beam radiation therapy for various cancers. Most of these agents have, unfortunately, displayed relatively poor pharmacokinetic properties, which…
-
Artikel Jurnal Teks lengkap
A Modular Supramolecular Peptide Platform Reveals Atomic-Number-Dependent Mechanisms Driving Radioenhancement
Optimizing radioenhancer design for cancer therapy has been limited by inconsistent metal comparisons and unclear nanoscale mechanisms. High-Z nanoparticles are expected to enhance radiation effects through increased photoelectric absorption and secondary electron production, with the common…
-
Artikel Jurnal Teks lengkap
NIR-emissive PEG-b-TCL Micelles for Breast Tumor Imaging and Minimally Invasive Pharmacokinetic Analysis
Motivated by the goal of developing a fully biodegradable optical contrast agent with translational clinical potential, a nanoparticle delivery vehicle was generated from the self-assembly of poly(ethylene-glycol)-block-poly(trimethylene carbonate-co-caprolactone) (PEG-b-TCL) copolymers. Cryogenic…
-
Artikel Jurnal Teks lengkap
Gadolinium-Based Nanoparticles and Radiation Therapy for Multiple Brain Melanoma Metastases: Proof of Concept before Phase I Trial
Nanoparticles containing high-Z elements are known to boost the efficacy of radiation therapy. Gadolinium (Gd) is particularly attractive because this element is also a positive contrast agent for MRI, which allows for the simultaneous use of imaging to guide the irradiation and to delineate the…
-
Artikel Jurnal Teks lengkap
TROIKA‐1: A double‐blind, randomized, parallel group, study aimed to demonstrate the equivalent pharmacokinetic profile of HD201, a potential biosimilar candidate to trastuzumab, versus EU‐Herceptin(®) and US‐Herceptin(®) in healthy male subjects
Prestige Biopharma Ltd (Singapore) has developed HD201, a proposed biosimilar to reference product trastuzumab. As a part of the stepwise approach to ensure comparability between the biosimilar candidate and the reference medicinal product, a phase I study in healthy subjects was conducted to…
-
Artikel Jurnal Teks lengkap
Comparative Preclinical Evaluation of Tuznue Versus Referent Herceptin: A Registered Trastuzumab Biosimilar
INTRODUCTION: The high cost of trastuzumab (Herceptin(®)) limits its accessibility for patients worldwide. Biosimilars, such as Tuznue(®) (HD201), represent a promising alternative to improve access to this essential therapy for HER2-positive breast cancer. This study aims to assess the similarity…